Happy New Year from Purespring. We’re kicking off 2026 by unveiling our new website! The launch reflects our ongoing progress as we prepare to enter the clinic this quarter. Take a look here: https://t.co/N0m5AaDXVa #Biotech #Innovation #KidneyDiseases #Podocyte

What a year 2025 has been. Thank you to our exceptional and dedicated team for delivering important #milestones for PS-002, including EMA orphan drug designation, FDA IND clearance, and UK CTA approval for our Phase I/II trial. Happy holidays from the Purespring team! #2026

From 12-15 January, the Purespring management team will be in San Francisco, CA for #JPM26. If you are also attending and would like to learn more about our #PrecisionNephrology approach to preserve kidney function, please reach out to arrange a meeting. #KidneyDisease

Getting into the festive spirit, the Purespring team attended @Kidney_Research's first Christmas Carol Concert, uniting the renal community to raise awareness and celebrate progress in kidney #research. #KidneyDisease #Christmas

Our CEO, Haseeb Ahmad, CFO, Sachin Kelkar & VP Business Development and Strategy Nicholas Deakin will be in New York from 2-4 December to #present and participate in 1-to-1 meetings at @Piper_Sandler's 37th Annual Healthcare Conference. To learn more: https://t.co/bXpgRg5AJa

Purespring has been featured as one of @MedCityHQ’s #LifeSciences Companies to Watch 2025, highlighting the strength of our #leadership team, recent progress and potential of our first-in-class genetic therapies to preserve kidney function. Read more here: https://t.co/MNyER6Liwz

The Purespring team have left Houston, feeling energised after an engaging #ASN2025! Thank you to ASN #KidneyWeek2025 organisers for an exceptional program, and we are already looking forward to next year! #GeneticMedicines #KidneyDiseases #Biotech

The Purespring management team will be in London next week for the @Jefferies London #HealthcareConference. If you will also be there and would like to discuss our targeted, first-in-class genetic therapies to preserve kidney function, please get in touch. #KidneyDiseases

Our Co-founder & Chief Scientific Advisor, Moin Saleem, and CMO, Fredrik Erlandsson, will be presenting at the @ASN #KidneyWeek2025 in Houston, TX, from November 5-9! To learn more: https://t.co/SAT200zf4d #GeneticMedicines #KidneyDiseases #Biotech

We are thrilled to #welcome Dr Nick Deakin, who joins Purespring as VP, Head of #BusinessDevelopment and Strategy. With an extensive background in defining and executing on strategic opportunities, his expertise will be critical as we enter our next phase of growth. #Leadership

Our CFO, Sachin Kelkar, and CSO, Alice Brown, will be in New York City on 21 October to present at @ChardanCM’s 9th Annual #GeneticMedicinesConference. If you would like to learn more, reach out to set up a meeting: https://t.co/AS7puS8tzS #PrecisionNephrology #CGMC2025

On 1 October, Fredrik Erlandsson, CMO, will be presenting ‘Advancing #PrecisionNephrology & #Podocyte Targeted Therapies' at the 5th Annual Rare & Genetic #KidneyDisease Drug Development Summit from 12:00-12:30EDT. Be sure to stop by if you are also attending. #Biotech #Kidney

On 17 September, Purespring’s management team will be participating in 1:1 meetings at the @BankofAmerica Healthcare Trailblazers Private Company Conference in Boston. Please reach out if you wish to learn more about Purespring’s innovative #pipeline: https://t.co/X5SpQPUC4K

Our CEO, Haseeb Ahmad, and CFO, Sachin Kelkar, will be in New York City from 8-10 Sept. to attend the @MorganStanley Global #Healthcare Conference. If you are also attending and want to learn more about our precision nephrology approach, please reach out to arrange a meeting.

We are thrilled to announce that we have received CTA approval from the UK MHRA, NHS HRA and REC for PS-002, our lead programme initially targeting #IgAN. This will enable initiation of a Phase I/II #ClinicalTrial in Q4 2025. For more https://t.co/szkufteXby

This week, Sandra Currie, CEO of @Kidney_Research, and her team shared an inspiring talk about their work funding research, raising awareness & improving treatments for #kidneydisease. We’re proud to have raised £1,400 at the #LondonBridgesWalk to support this vital cause.

We are excited to announce we have received FDA #IND clearance for PS-002, our lead programme initially targeting IgAN disease. This will enable the initiation of a Phase I/II #ClinicalTrial later this year. For more https://t.co/Q9ATdL72Eu #KidneyDisease

Throughout the month of June, Purespring has been celebrating #PrideMonth. We believe that scientific excellence and #innovation rely on #diversity, and, guided by our core values, we aim to create an inclusive environment where everyone is free to be themselves. #KidneyDisease

🔊Listen now to a special episode of @LaBiotech_eu's 'Beyond Biotech' podcast, in which our CEO, Haseeb Ahmad, speaks on his experience at the 2025 @IAmBiotech International Convention: https://t.co/yt42SPsJcW #BIO2025 #KidneyDisease #Biotech

We are thrilled to have been identified by @Labiotech_eu as one of the six #KidneyDisease companies you should know about in 2025, highlighting our commitment to transforming the treatment paradigm via our precision #nephrology approach: https://t.co/Wr8GDOyIKv #Biotech